EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Feb 07, 2024 | Sale | $10.97 | 35,986 | 394,590 | 17,993 | Feb 09, 2024, 05:43 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Feb 08, 2024 | Sale | $10.97 | 7,626 | 83,644 | 3,813 | Feb 09, 2024, 05:43 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Feb 09, 2024 | Option Exercise | $10.97 | 16,058 | 176,153 | 8,029 | Feb 09, 2024, 05:43 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Dec 27, 2023 | Sale | $10.50 | 8,497 | 89,219 | 0 | Dec 28, 2023, 04:39 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | May 02, 2023 | Sale | $8.90 | 1,897 | 16,893 | 6,565 | May 03, 2023, 06:26 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Oct 03, 2022 | Sale | $5.84 | 9,460 | 55,284 | 7,730 | Oct 05, 2022, 04:42 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Sep 06, 2022 | Sale | $6.42 | 9,460 | 60,727 | 7,730 | Sep 08, 2022, 04:16 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Aug 03, 2022 | Option Exercise | $5.32 | 18,464 | 98,247 | 12,232 | Aug 05, 2022, 04:12 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jul 05, 2022 | Option Exercise | $4.80 | 16,372 | 78,635 | 11,186 | Jul 07, 2022, 04:23 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jul 06, 2022 | Sale | $5.23 | 2,092 | 10,947 | 4,046 | Jul 07, 2022, 04:23 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 16, 2022 | Option Exercise | $4.05 | 29,444 | 119,219 | 17,722 | Jun 21, 2022, 06:50 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 17, 2022 | Option Exercise | $4.27 | 44,254 | 189,139 | 25,127 | Jun 21, 2022, 06:50 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 21, 2022 | Sale | $4.35 | 62,156 | 270,196 | 34,078 | Jun 21, 2022, 06:50 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 14, 2022 | Option Exercise | $3.37 | 7,256 | 24,431 | 6,628 | Jun 15, 2022, 06:39 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 15, 2022 | Sale | $3.43 | 37,320 | 127,982 | 21,660 | Jun 15, 2022, 06:39 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 13, 2022 | Option Exercise | $3.36 | 8,186 | 27,488 | 7,093 | Jun 15, 2022, 06:39 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 08, 2022 | Sale | $3.67 | 25,132 | 92,283 | 15,566 | Jun 10, 2022, 06:34 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 09, 2022 | Sale | $3.60 | 15,230 | 54,804 | 10,615 | Jun 10, 2022, 06:34 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 10, 2022 | Option Exercise | $3.38 | 14,250 | 48,179 | 10,125 | Jun 10, 2022, 06:34 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 06, 2022 | Sale | $3.98 | 27,868 | 110,977 | 16,934 | Jun 07, 2022, 07:03 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 07, 2022 | Sale | $3.69 | 36,246 | 133,757 | 20,150 | Jun 07, 2022, 07:03 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jun 03, 2022 | Sale | $3.99 | 30,460 | 121,592 | 18,230 | Jun 07, 2022, 07:03 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | May 16, 2022 | Sale | $7.42 | 10,800 | 80,146 | 3,000 | May 18, 2022, 05:15 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Jan 21, 2022 | Option Exercise | $0.71 | 5,400 | 3,834 | 12,362 | Jan 25, 2022, 06:50 PM |
EWTX | | Edgewise Therapeutics, Inc. | MOORE JOHN R | General Counsel | Dec 28, 2021 | Option Exercise | $0.71 | 5,400 | 3,834 | 6,962 | Dec 30, 2021, 05:51 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 01, 2017 | Option Exercise | $8.94 | 6,370 | 56,948 | 40,102 | Apr 06, 2017, 08:30 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 01, 2017 | Option Exercise | $8.94 | 4,408 | 39,408 | 42,064 | Apr 04, 2017, 09:41 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 01, 2016 | Option Exercise | $3.00 | 2,505 | 7,515 | 39,754 | Apr 05, 2016, 06:54 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Mar 01, 2015 | Option Exercise | $7.96 | 30,448 | 242,366 | 22,906 | Mar 04, 2015, 08:14 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Nov 29, 2013 | Sale | $5.79 | 11,666 | 67,546 | 20 | Dec 03, 2013, 04:34 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Nov 13, 2013 | Sale | $5.79 | 200 | 1,158 | 11,686 | Nov 15, 2013, 05:22 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Aug 01, 2013 | Sale | $5.11 | 58,241 | 297,751 | 43,386 | Aug 02, 2013, 06:24 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Aug 02, 2013 | Option Exercise | $5.04 | 87,768 | 442,060 | 55,770 | Aug 02, 2013, 06:24 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jul 23, 2013 | Sale | $4.62 | 10,000 | 46,200 | 16,886 | Jul 25, 2013, 07:42 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jul 25, 2013 | Option Exercise | $3.75 | 4,759 | 17,846 | 16,645 | Jul 25, 2013, 07:42 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 23, 2013 | Option Exercise | $4.63 | 40,000 | 185,200 | 31,886 | Apr 24, 2013, 07:06 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Oct 08, 2012 | Sale | $5.69 | 2,357 | 13,401 | 0 | Oct 09, 2012, 05:32 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Oct 08, 2012 | Sale | $5.69 | 26,190 | 148,911 | 11,886 | Oct 09, 2012, 05:32 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Apr 05, 2011 | Sale | $3.30 | 356 | 1,175 | 0 | Apr 05, 2011, 04:10 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jan 10, 2011 | Sale | $3.30 | 593 | 1,957 | 2,722 | Jan 12, 2011, 05:53 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jan 11, 2011 | Sale | $3.30 | 2,366 | 7,808 | 356 | Jan 12, 2011, 05:53 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Jan 06, 2011 | Sale | $3.25 | 24,039 | 78,127 | 0 | Jan 06, 2011, 05:11 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Oct 05, 2010 | Sale | $3.29 | 20,067 | 66,020 | 24,039 | Oct 06, 2010, 04:46 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Aug 02, 2010 | Sale | $3.25 | 2,840 | 9,230 | 23,546 | Aug 04, 2010, 04:12 PM |
ARRY | | ARRAY BIOPHARMA INC | MOORE JOHN R | VP, General Counsel | Aug 03, 2010 | Sale | $3.25 | 3,479 | 11,307 | 20,067 | Aug 04, 2010, 04:12 PM |